Antibiotics in sepsis.

Division of Infectious Diseases, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.
Intensive Care Medicine (Impact Factor: 5.54). 02/2001; 27 Suppl 1(14):S33-48. DOI: 10.1007/PL00003796
Source: PubMed
Download full-text


Available from: Pierre-Yves Bochud, Jul 05, 2015
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Sepsis, a serious cause of morbidity in humans, has no proper single medication dedicated to it. In this review, we look at the current treatment modalities, the different approaches attempted towards treating it and alternative approaches that could be implemented to counter this neglected disease condition. The use of antibiotics towards treatment of sepsis, use of combinations and strategies derived from natural antimicrobial peptides has been dealt with in details. The social and technical difficulties associated with treating sepsis and the possible ways of combating them have also been discussed. Copyright © 2015. Published by Elsevier Ltd.
    Microbial Pathogenesis 02/2015; 80. DOI:10.1016/j.micpath.2015.02.001 · 2.00 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: This article is a brief overview of empiric antibiotic selection for sepsis and septic shock. The article includes a differential diagnosis of the mimics of sepsis and stresses a strategy for avoiding problems associated with antibiotic resistance. Although early appropriate empiric therapy is the cornerstone of sepsis and septic shock therapy, nonantibiotic interventions are critical as well. In patients with septic shock, adequate and effective early volume replacement is essential. Early surgical intervention is critical in controlling and eliminating the septic focus if sepsis is related to perforation of a viscus (eg, the colon); obstruction of the biliary, gastrointestinal, or urinary tract; or presence of an abscess that requires drainage. If device-related infection is the cause of sepsis, device removal is essential. Empiric monotherapy for sepsis and septic shock is preferred. Multiple-drug therapy is more expensive, has an increased potential for drug-drug interactions, has a higher likelihood of side effects, and does not decrease the resistance potential of the antibiotics being used. For these reasons, early empiric monotherapy is optimal and de-escalation is not necessary if initial mono therapy was wisely selected.
    Critical Care Clinics 05/2008; 24(2):313-34, ix. DOI:10.1016/j.ccc.2007.12.015 · 2.50 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Increased attention has focused recently on the acute management of severe sepsis and septic shock, conditions that represent the end-stage systemic deterioration of overwhelming infection. Clinical trials have identified new therapies and management approaches that, when applied early, appear to reduce mortality. Practice guidelines have been advanced by critical care societies, and many of the proposed interventions involve therapies other than antimicrobials directed at hemodynamic resuscitation or addressing adverse effects of the inflammatory cascade. Although many emergency departments (EDs) are now adopting treatment protocols for sepsis that are based on published treatment guidelines, recent research calls many of the initial recommendations into question, and validation trials of some of these approaches are ongoing. This article reviews the initial evaluation and treatment considerations of sepsis in the ED setting.
    Infectious Disease Clinics of North America 04/2008; 22(1):1-31, v. DOI:10.1016/j.idc.2007.09.005 · 2.31 Impact Factor